<link rel="stylesheet" href="css/cards.css">
<div style="margin-top: 40px;margin-left:5%;margin-right:5%;">

    <nav aria-label="breadcrumb">
        <ol class="breadcrumb">
            <li class="breadcrumb-item"><a href="index.html">Home</a></li>
            <li class="breadcrumb-item active" aria-current="page">Paralytics</li>
        </ol>
    </nav>


    <div class="mainContent">
        <h2>Drugs</h2>
        <br>
        <!-- Nav tabs -->
        <ul class="nav nav-tabs" id="myTab" role="tablist">
            <li class="nav-item">
                <a class="nav-link active" id="pancuronium-tab" data-toggle="tab" href="#pancuronium" role="tab"
                    aria-controls="pancuronium" aria-selected="true">Pancuronium</a>
            </li>
            <li class="nav-item">
                <a class="nav-link" id="CISATRACURIUM-tab" data-toggle="tab" href="#CISATRACURIUM" role="tab"
                    aria-controls="CISATRACURIUM" aria-selected="false">CISATRACURIUM</a>
            </li>
            <li class="nav-item">
                <a class="nav-link" id="Rocuronium-tab" data-toggle="tab" href="#Rocuronium" role="tab"
                    aria-controls="Rocuronium" aria-selected="false">Rocuronium</a>
            </li>
            <li class="nav-item">
                <a class="nav-link" id="Succinylcholine-tab" data-toggle="tab" href="#Succinylcholine" role="tab"
                    aria-controls="Succinylcholine" aria-selected="false">Succinylcholine</a>
            </li>
            <li class="nav-item">
                <a class="nav-link" id="Vecuronium-tab" data-toggle="tab" href="#Vecuronium" role="tab"
                    aria-controls="Vecuronium" aria-selected="false">Vecuronium (Norcuron)
                </a>
            </li>
        </ul>

        <!-- Tab panes -->
        <div class="tab-content">
            <div class="tab-pane active" id="pancuronium" role="tabpanel" aria-labelledby="pancuronium-tab">
                <div class="mainContent">
                    <ul class="nav nav-pills mb-3" id="pancuronium-tab" role="tablist">
                        <li class="nav-item">
                            <a class="nav-link active" id="pancuronium-dosing-tab" data-toggle="pill"
                                href="#pancuronium-dosing" role="tab" aria-controls="pancuronium-dosing"
                                aria-selected="true">Dosing</a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link" id="pancuronium-CONTRAINDICATIONS-PRECAUTIONS-tab" data-toggle="pill"
                                href="#pancuronium-CONTRAINDICATIONS-PRECAUTIONS" role="tab"
                                aria-controls="pancuronium-CONTRAINDICATIONS-PRECAUTIONS"
                                aria-selected="false">CONTRAINDICATIONS /
                                PRECAUTIONS</a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link" id="pancuronium-BOXED-WARNING-tab" data-toggle="pill"
                                href="#pancuronium-BOXED-WARNING" role="tab" aria-controls="pancuronium-BOXED-WARNING"
                                aria-selected="false">BOXED WARNING</a>
                        </li>
                    </ul>
                    <div class="tab-content" id="pancuronium-tabContent">
                        <div class="tab-pane fade show active" id="pancuronium-dosing" role="tabpanel"
                            aria-labelledby="pancuronium-dosing-tab">
                            <div class="mainContent" id="Pancuronium-DOSING">
                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse" href="#Pancuronium-DOSINGcollapseOne"
                                        role="button" aria-expanded="false"
                                        aria-controls="Pancuronium-DOSINGcollapseOne">
                                        <div class="card-header" id="Pancuronium-DOSINGheadingOne">
                                            <h1 class="card-heading">For the treatment of refractory agitation in the
                                                intensive care unit patient.
                                                Intravenous dosage</h1>
                                        </div>
                                    </a>

                                    <div id="Pancuronium-DOSINGcollapseOne" class="collapse"
                                        aria-labelledby="Pancuronium-DOSINGheadingOne"
                                        data-parent="#Pancuronium-DOSING">
                                        <div class="card-body">
                                            <h3>Adults</h3>
                                            <p>Initial doses of 0.04 to 0.1 mg/kg IV have been recommended in patients
                                                with agitation not controlled
                                                with large doses of neuroleptics, benzodiazepines, or morphine. Repeat
                                                doses should be based on
                                                clinical goals and patient response (e.g., peripheral nerve stimulation
                                                monitoring). NOTE:
                                                Nondepolarizing muscle relaxants cause paralysis without altering
                                                consciousness; liberal doses of
                                                morphine or midazolam should be used to ensure tranquility</p>
                                        </div>
                                    </div>
                                </div>
                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse" href="#Pancuronium-DOSINGcollapseTwo"
                                        role="button" aria-expanded="false"
                                        aria-controls="Pancuronium-DOSINGcollapseTwo">
                                        <div class="card-header" id="Pancuronium-DOSINGheadingTwo">
                                            <h1 class="card-heading">MAXIMUM DOSAGE</h1>
                                        </div>
                                    </a>
                                    <div id="Pancuronium-DOSINGcollapseTwo" class="collapse"
                                        aria-labelledby="Pancuronium-DOSINGheadingTwo"
                                        data-parent="#Pancuronium-DOSING">
                                        <div class="card-body">
                                            <p class="card-p">
                                                Specific maximum dosage information is not available. Dosage must
                                                be individualized based on clinical response
                                            </p>
                                        </div>
                                    </div>
                                </div>
                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse" href="#Pancuronium-DOSINGcollapseThree"
                                        role="button" aria-expanded="false"
                                        aria-controls="Pancuronium-DOSINGcollapseThree">
                                        <div class="card-header" id="Pancuronium-DOSINGheadingThree">
                                            <h1 class="card-heading">DOSING CONSIDERATIONS</h1>
                                        </div>
                                    </a>
                                    <div id="Pancuronium-DOSINGcollapseThree" class="collapse"
                                        aria-labelledby="Pancuronium-DOSINGheadingThree"
                                        data-parent="#Pancuronium-DOSING">
                                        <div class="card-body">
                                            <h3>Hepatic Impairment</h3>
                                            <p class="card-p">
                                                Hepatic impairment may prolong the duration of action of pancuronium.
                                                Specific guidelines for
                                                dosage adjustments in hepatic impairment are not available; dosage
                                                reductions may be necessary.
                                            </p>
                                            <h3>Renal Impairment</h3>
                                            <p class="card-p">
                                                Initial dosage should be modified based on clinical goals and the degree
                                                of renal impairment.
                                                Individualize further dosage based on patient response (e.g., peripheral
                                                nerve stimulation
                                                monitoring). Renal failure may prolong the duration of action of
                                                pancuronium.
                                                Dosage adjustments for pediatric patients are as follows:
                                                CrCl > 50 mL/minute/1.73 m2: No initial dosage adjustment required;
                                                monitor carefully and adjust
                                                dosage to clinical effect.
                                                CrCl 10 to 50 mL/minute/1.73 m2: Administer 50% of normal dosage;
                                                monitor carefully and adjust
                                                dosage to clinical effect.
                                                CrCl &lt; 10 mL/minute/1.73 m2: Avoid use </p>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="tab-pane fade" id="pancuronium-CONTRAINDICATIONS-PRECAUTIONS" role="tabpanel"
                            aria-labelledby="pancuronium-CONTRAINDICATIONS-PRECAUTIONS-tab">
                            <div class="mainContent" id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONS">
                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse"
                                        href="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseOne" role="button"
                                        aria-expanded="false"
                                        aria-controls="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseOne">
                                        <div class="card-header"
                                            id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingOne">
                                            <h1 class="card-heading">General Information</h1>
                                        </div>
                                    </a>

                                    <div id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseOne" class="collapse"
                                        aria-labelledby="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingOne"
                                        data-parent="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONS">
                                        <div class="card-body">
                                            Pancuronium does not cause sedation or analgesia and should be administered
                                            only after
                                            unconsciousness has been induced. Amnesia and analgesia should be adequately
                                            maintained
                                            throughout paralyzation. Doses of pancuronium should be individualized. Use
                                            of a peripheral nerve
                                            stimulator will permit the most advantageous use of pancuronium, minimize
                                            the possibility of
                                            overdosage or underdosage, and assist in the evaluation of recovery.
                                        </div>
                                    </div>
                                </div>

                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse"
                                        href="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseTwo" role="button"
                                        aria-expanded="false"
                                        aria-controls="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseTwo">
                                        <div class="card-header"
                                            id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingTwo">
                                            <h1 class="card-heading">Requires an experienced clinician, respiratory
                                                insufficiency</h1>
                                        </div>
                                    </a>

                                    <div id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseTwo" class="collapse"
                                        aria-labelledby="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingTwo"
                                        data-parent="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONS">
                                        <div class="card-body">
                                            Neuromuscular blocking agents cause respiratory insufficiency by paralyzing
                                            respiratory muscles.
                                            Administration requires an experienced clinician who is adequately trained
                                            and familiar with the
                                            actions, characteristics, and hazards of pancuronium. These personnel should
                                            be skilled in airway
                                            management and respiratory support. Equipment and personnel must be
                                            immediately available for
                                            intubation and support of ventilation, including administration of oxygen
                                            therapy. Adequacy of
                                            respiration must be assured through assisted or controlled ventilation.
                                            Reversal agents must be
                                            immediately available.
                                        </div>
                                    </div>
                                </div>

                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse"
                                        href="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseThree" role="button"
                                        aria-expanded="false"
                                        aria-controls="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseThree">
                                        <div class="card-header"
                                            id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingThree">
                                            <h1 class="card-heading">Labor, obstetric delivery, pregnancy</h1>
                                        </div>
                                    </a>

                                    <div id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseThree" class="collapse"
                                        aria-labelledby="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingThree"
                                        data-parent="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONS">
                                        <div class="card-body">
                                            Use pancuronium during pregnancy only if the benefits outweigh the risks. It
                                            is not known whether
                                            pancuronium can cause fetal harm when administered to a pregnant woman or if
                                            it can affect
                                            reproduction capacity. Pancuronium may be used in obstetric delivery (i.e.,
                                            cesarean section), but
                                            reversal of pancuronium may be unsatisfactory in patients receiving
                                            magnesium sulfate for toxemia
                                            of pregnancy because magnesium salts enhance neuromuscular blockade. Reduce
                                            pancuronium
                                            dosage, as indicated, in such cases. It is also recommended that the
                                            interval between pancuronium
                                            use and labor and obstetric delivery be reasonably short to avoid clinically
                                            significant placental
                                            transfer. Animal reproduction studies of pancuronium have not been
                                            performed.[41961]
                                        </div>
                                    </div>
                                </div>

                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse"
                                        href="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseFour" role="button"
                                        aria-expanded="false"
                                        aria-controls="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseFour">
                                        <div class="card-header"
                                            id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingFour">
                                            <h1 class="card-heading">Breast-feeding</h1>
                                        </div>
                                    </a>

                                    <div id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseFour" class="collapse"
                                        aria-labelledby="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingFour"
                                        data-parent="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONS">
                                        <div class="card-body">
                                            There are no data on the presence of pancuronium in human milk, the effects
                                            on the breast-fed
                                            infant, or the effects on milk production. The elimination half-life for
                                            pancuronium is 1.5 to 3 hours.
                                            It
                                            is a bisquaternary ammonium compound and should pass slowly through
                                            biological membranes. If
                                            trace amounts were excreted into breast milk, quaternary ammonium muscle
                                            relaxants are poorly
                                            absorbed from the gastrointestinal tract. Based on these data,
                                            breast-feeding could be allowed as
                                            soon as practically feasible after recovery from a surgical procedure.
                                        </div>
                                    </div>
                                </div>

                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse"
                                        href="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseFive" role="button"
                                        aria-expanded="false"
                                        aria-controls="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseFive">
                                        <div class="card-header"
                                            id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingFive">
                                            <h1 class="card-heading">Chronic obstructive pulmonary disease (COPD),
                                                pulmonary disease, respiratory
                                                depression</h1>
                                        </div>
                                    </a>

                                    <div id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseFive" class="collapse"
                                        aria-labelledby="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingFive"
                                        data-parent="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONS">
                                        <div class="card-body">
                                            Neuromuscular blocking agents can cause respiratory paralysis as a result of
                                            respiratory depression
                                            and should be used with extreme caution in patients with pulmonary disease
                                            such as chronic
                                            obstructive pulmonary disease (COPD). In addition, patients with severe
                                            obesity may be
                                            predisposed to airway or ventilatory problems which require special care
                                            before, during, and after
                                            treatment with pancuronium.
                                        </div>
                                    </div>
                                </div>


                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse"
                                        href="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseSix" role="button"
                                        aria-expanded="false"
                                        aria-controls="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseSix">
                                        <div class="card-header"
                                            id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingSix">
                                            <h1 class="card-heading">Bromide hypersensitivity, neuromuscular blocking
                                                agent hypersensitivity</h1>
                                        </div>
                                    </a>

                                    <div id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseSix" class="collapse"
                                        aria-labelledby="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingSix"
                                        data-parent="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONS">
                                        <div class="card-body">
                                            Pancuronium is contraindicated in patients known to have hypersensitivity to
                                            pancuronium or a
                                            bromide hypersensitivity. Pancuronium should be used with caution in
                                            patients with a neuromuscular
                                            blocking agent hypersensitivity, as cross-reactivity has been reported with
                                            both depolarizing and
                                            non-depolarizing agents in this class.
                                        </div>
                                    </div>
                                </div>


                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse"
                                        href="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseSeven" role="button"
                                        aria-expanded="false"
                                        aria-controls="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseSeven">
                                        <div class="card-header"
                                            id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingSeven">
                                            <h1 class="card-heading">Lung cancer, myasthenia gravis, myopathy,
                                                neuromuscular disease, obesity</h1>
                                        </div>
                                    </a>

                                    <div id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseSeven" class="collapse"
                                        aria-labelledby="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingSeven"
                                        data-parent="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONS">
                                        <div class="card-body">
                                            Patients with conditions that impair neuromuscular function can experience
                                            prolonged or
                                            exaggerated neuromuscular block with nondepolarizing agents. These
                                            conditions include
                                            myasthenia gravis, myasthenic syndrome associated with small cell
                                            carcinomatosis (Eaton Lambert
                                            syndrome; originally associated with lung cancer), myopathy, or any other
                                            neuromuscular disease.
                                            Additionally, patients with weak muscle tone and those who suffer from
                                            severe obesity are at an
                                            increased risk for airway and ventilation complications. Use vecuronium with
                                            caution in patients with
                                            these conditions, and continue to monitor patients carefully until recovery
                                            is fully complete.
                                        </div>
                                    </div>
                                </div>

                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse"
                                        href="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseEight" role="button"
                                        aria-expanded="false"
                                        aria-controls="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseEight">
                                        <div class="card-header"
                                            id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingEight">
                                            <h1 class="card-heading">Asthma, cardiac disease, edema</h1>
                                        </div>
                                    </a>

                                    <div id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseEight" class="collapse"
                                        aria-labelledby="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingEight"
                                        data-parent="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONS">
                                        <div class="card-body">
                                            Neuromuscular blocking agents stimulate histamine release. Compared with
                                            other neuromuscular
                                            blockers, pancuronium produces minimal stimulation, but it should be used
                                            with caution in any
                                            condition in which a significant release of histamine may be
                                            contraindicated, such as cardiac disease
                                            or asthma. In addition, use pancuronium with caution in patients with
                                            cardiac disease or other
                                            conditions that may be associated with a slower circulation time. Changes in
                                            the volume of
                                            distribution related to poor circulation or edema can delay the onset of
                                            neuromuscular blockade.
                                            Particular care is required when administering subsequent doses when it is
                                            uncertain whether
                                            maximum effect has been attained.
                                        </div>
                                    </div>
                                </div>


                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse"
                                        href="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseNine" role="button"
                                        aria-expanded="false"
                                        aria-controls="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseNine">
                                        <div class="card-header"
                                            id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingNine">
                                            <h1 class="card-heading">Acid/base imbalance, adrenal insufficiency,
                                                dehydration, electrolyte imbalance,
                                                hypercalcemia, hypermagnesemia, hypocalcemia, hypokalemia, hypothermia,
                                                metabolic alkalosis, respiratory acidosis</h1>
                                        </div>
                                    </a>

                                    <div id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseNine" class="collapse"
                                        aria-labelledby="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingNine"
                                        data-parent="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONS">
                                        <div class="card-body">
                                            Various physiologic states can alter the expected effects of pancuronium;
                                            carefully consider each
                                            patient's clinical condition when dosing pancuronium and monitoring the
                                            patient. Electrolyte
                                            imbalance can alter a patient's sensitivity to neuromuscular blocking agents
                                            (NMBAs).
                                            Hypercalcemia can decrease sensitivity to NMBAs, while most other
                                            electrolyte disturbances
                                            increase sensitivity (e.g., hypokalemia, hypocalcemia, hypermagnesemia). Use
                                            vecuronium
                                            cautiously in patients with conditions that may lead to electrolyte
                                            imbalances, such as adrenal
                                            insufficiency. Severe acid/base imbalance may alter a patient's sensitivity
                                            to NMBAs: respiratory
                                            acidosis may enhance neuromuscular blockade and metabolic alkalosis may
                                            counteract it.
                                            Dehydration and hypothermia can also increase a patient's sensitivity to
                                            NMBAs.
                                        </div>
                                    </div>
                                </div>

                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse"
                                        href="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseTen" role="button"
                                        aria-expanded="false"
                                        aria-controls="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseTen">
                                        <div class="card-header"
                                            id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingTen">
                                            <h1 class="card-heading">Malignant hyperthermia</h1>
                                        </div>
                                    </a>

                                    <div id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseTen" class="collapse"
                                        aria-labelledby="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingTen"
                                        data-parent="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONS">
                                        <div class="card-body">
                                            Patients with a familial history of malignant hyperthermia should be treated
                                            with extreme caution.
                                            The condition can be precipitated by the use of halogenated anesthetics
                                            because this reaction has
                                            been attributed to their use, but neuromuscular blocking agents (such as
                                            pancuronium) also may be
                                            a contributory factor.
                                        </div>
                                    </div>
                                </div>

                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse"
                                        href="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseEleven" role="button"
                                        aria-expanded="false"
                                        aria-controls="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseEleven">
                                        <div class="card-header"
                                            id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingEleven">
                                            <h1 class="card-heading">Tachycardia</h1>
                                        </div>
                                    </a>

                                    <div id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseEleven" class="collapse"
                                        aria-labelledby="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingEleven"
                                        data-parent="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONS">
                                        <div class="card-body">
                                            Pancuronium increases the heart rate, probably by a direct action on the
                                            acetylcholine receptors in
                                            the heart. Patients with tachycardia should be treated with caution,
                                            although the effect appears to be
                                            dose-related and minimal in the usual dosage range.
                                        </div>
                                    </div>
                                </div>

                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse"
                                        href="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseTwelve" role="button"
                                        aria-expanded="false"
                                        aria-controls="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseTwelve">
                                        <div class="card-header"
                                            id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingTwelve">
                                            <h1 class="card-heading">Renal failure, renal impairment</h1>
                                        </div>
                                    </a>

                                    <div id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseTwelve" class="collapse"
                                        aria-labelledby="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingTwelve"
                                        data-parent="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONS">
                                        <div class="card-body">
                                            Pancuronium should be used with caution in patients with renal impairment.
                                            The elimination half-life
                                            is doubled and plasma clearance is decreased by about 60% in patients with
                                            renal failure.
                                            Neuromuscular blockade can be prolonged.
                                        </div>
                                    </div>
                                </div>

                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse"
                                        href="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseThirteen" role="button"
                                        aria-expanded="false"
                                        aria-controls="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseThirteen">
                                        <div class="card-header"
                                            id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingThirteen">
                                            <h1 class="card-heading">Biliary obstruction, hepatic disease</h1>
                                        </div>
                                    </a>

                                    <div id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseThirteen" class="collapse"
                                        aria-labelledby="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingThirteen"
                                        data-parent="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONS">
                                        <div class="card-body">
                                            Pancuronium should be used with caution in patients with hepatic disease.
                                            The elimination half-life is
                                            doubled in patients with biliary obstruction or cirrhosis and plasma
                                            clearance is decreased by &lt;50%
                                            or about 22%, respectively. In addition, patients with hepatic disease may
                                            have a 50% increase in
                                            the volume of distribution of pancuronium. This usually results in the need
                                            for a higher initial dose to
                                            achieve adequate muscle relaxation and a prolonged duration of action.
                                        </div>
                                    </div>
                                </div>

                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse"
                                        href="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseFourteen" role="button"
                                        aria-expanded="false"
                                        aria-controls="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseFourteen">
                                        <div class="card-header"
                                            id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingFourteen">
                                            <h1 class="card-heading">Burns</h1>
                                        </div>
                                    </a>

                                    <div id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseFourteen" class="collapse"
                                        aria-labelledby="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingFourteen"
                                        data-parent="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONS">
                                        <div class="card-body">
                                            Patients with extensive burns can exhibit a decreased response to the
                                            effects of pancuronium.
                                            Resistance to neuromuscular blockade peaks after about 2 weeks and gradually
                                            declines as the
                                            burns heal. Increased doses of pancuronium may be required in these
                                            patients.
                                        </div>
                                    </div>
                                </div>


                                <div class="card">
                                    <a class="collapsed" data-toggle="collapse"
                                        href="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseFiveteen" role="button"
                                        aria-expanded="false"
                                        aria-controls="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseFiveteen">
                                        <div class="card-header"
                                            id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingFiveteen">
                                            <h1 class="card-heading">Neonates, premature neonates</h1>
                                        </div>
                                    </a>

                                    <div id="Pancuronium-CONTRAINDICATIONS-PRECAUTIONScollapseFiveteen" class="collapse"
                                        aria-labelledby="Pancuronium-CONTRAINDICATIONS-PRECAUTIONSheadingFiveteen"
                                        data-parent="#Pancuronium-CONTRAINDICATIONS-PRECAUTIONS">
                                        <div class="card-body">
                                            Pancuronium products contain benzyl alcohol as a preservative. For this
                                            reason, FDA-approved
                                            labeling for some formulations specifically contraindicates use in neonates
                                            and premature neonates.
                                            Large amounts of benzyl alcohol (more than 99 mg/kg/day) have been
                                            associated with gasping
                                            syndrome in this population. Gasping syndrome is characterized by central
                                            nervous depression,
                                            metabolic acidosis, and gasping respirations. Although normal therapeutic
                                            doses of pancuronium
                                            would deliver amounts of benzyl alcohol that are substantially lower than
                                            those reported to cause
                                            gasping syndrome, the minimum dose at which toxicity can occur is not known
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="tab-pane fade" id="pancuronium-BOXED-WARNING" role="tabpanel"
                            aria-labelledby="pancuronium-BOXED-WARNING-tab">
                            <div class="instruction">
                                <div class="instruction-section">
                                    <h5>Requires an experienced clinician, respiratory insufficiency</h5>

                                    Neuromuscular blocking agents cause respiratory insufficiency by paralyzing
                                    respiratory muscles.
                                    Administration requires an experienced clinician who is adequately trained and
                                    familiar with the
                                    actions, characteristics, and hazards of pancuronium. These personnel should be
                                    skilled in airway
                                    management and respiratory support. Equipment and personnel must be immediately
                                    available for
                                    intubation and support of ventilation, including administration of oxygen
                                    therapy. Adequacy of
                                    respiration must be assured through assisted or controlled ventilation. Reversal
                                    agents must be
                                    immediately available.
                                </div>
                            </div>
                        </div>
                    </div>

                </div>
            </div>
            <div class="tab-pane" id="CISATRACURIUM" role="tabpanel" aria-labelledby="CISATRACURIUM-tab">
                <div class="mainContent">
                    <ul class="nav nav-pills mb-3" id="cisatracurium-tab" role="tablist">
                        <li class="nav-item">
                            <a class="nav-link active" id="cisatracurium-dosing-tab" data-toggle="pill"
                                href="#cisatracurium-dosing" role="tab" aria-controls="cisatracurium-dosing"
                                aria-selected="true">Dosing</a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link" id="cisatracurium-CONTRAINDICATIONS-PRECAUTIONS-tab" data-toggle="pill"
                                href="#cisatracurium-CONTRAINDICATIONS-PRECAUTIONS" role="tab"
                                aria-controls="cisatracurium-CONTRAINDICATIONS-PRECAUTIONS"
                                aria-selected="false">CONTRAINDICATIONS /
                                PRECAUTIONS</a>
                        </li>
                    </ul>
                    <div class="tab-content" id="cisatracurium-tabContent">
                        <div class="tab-pane fade show active" id="cisatracurium-dosing" role="tabpanel"
                            aria-labelledby="cisatracurium-dosing-tab">
                            Dosing
                        </div>
                        <div class="tab-pane fade" id="cisatracurium-CONTRAINDICATIONS-PRECAUTIONS" role="tabpanel"
                            aria-labelledby="cisatracurium-CONTRAINDICATIONS-PRECAUTIONS-tab">
                            CONTRAINDICATIONS-PRECAUTIONS
                        </div>
                    </div>
                </div>
            </div>
            <div class="tab-pane" id="Rocuronium" role="tabpanel" aria-labelledby="Rocuronium-tab">
                <div class="mainContent">
                    <ul class="nav nav-pills mb-3" id="rocuronium-tab" role="tablist">
                        <li class="nav-item">
                            <a class="nav-link active" id="rocuronium-DOSAGE-INDICATIONS-tab" data-toggle="pill"
                                href="#rocuronium-DOSAGE-INDICATIONS" role="tab"
                                aria-controls="rocuronium-DOSAGE-INDICATIONS" aria-selected="true">DOSAGE &
                                INDICATIONS</a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link" id="rocuronium-DOSING-CONSIDERATIONS-tab" data-toggle="pill"
                                href="#rocuronium-DOSING-CONSIDERATIONS" role="tab"
                                aria-controls="rocuronium-DOSING-CONSIDERATIONS" aria-selected="false">DOSING
                                CONSIDERATIONS</a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link" id="rocuronium-CONTRAINDICATIONS-PRECAUTIONS-tab" data-toggle="pill"
                                href="#rocuronium-CONTRAINDICATIONS-PRECAUTIONS" role="tab"
                                aria-controls="rocuronium-CONTRAINDICATIONS-PRECAUTIONS"
                                aria-selected="false">CONTRAINDICATIONS /
                                PRECAUTIONS</a>
                        </li>
                    </ul>
                    <div class="tab-content" id="rocuronium-tabContent">
                        <div class="tab-pane fade show active" id="rocuronium-DOSAGE-INDICATIONS" role="tabpanel"
                            aria-labelledby="rocuronium-DOSAGE-INDICATIONS-tab">
                            DOSAGE-INDICATIONS
                        </div>
                        <div class="tab-pane fade" id="rocuronium-DOSING-CONSIDERATIONS" role="tabpanel"
                            aria-labelledby="rocuronium-DOSING-CONSIDERATIONS-tab">
                            DOSING-CONSIDERATIONS
                        </div>
                        <div class="tab-pane fade" id="rocuronium-CONTRAINDICATIONS-PRECAUTIONS" role="tabpanel"
                            aria-labelledby="rocuronium-CONTRAINDICATIONS-PRECAUTIONS-tab">
                            CONTRAINDICATIONS-PRECAUTIONS
                        </div>
                    </div>
                </div>
            </div>
            <div class="tab-pane" id="Succinylcholine" role="tabpanel" aria-labelledby="Succinylcholine-tab">
                <div class="mainContent">
                    <ul class="nav nav-pills mb-3" id="Succinylcholine-tab" role="tablist">
                        <li class="nav-item">
                            <a class="nav-link active" id="Succinylcholine-BOXED-WARNING-tab" data-toggle="pill"
                                href="#Succinylcholine-BOXED-WARNING" role="tab"
                                aria-controls="Succinylcholine-BOXED-WARNING" aria-selected="true">BOXED WARNING</a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link" id="Succinylcholine-DOSAGE-INDICATIONS-tab" data-toggle="pill"
                                href="#Succinylcholine-DOSAGE-INDICATIONS" role="tab"
                                aria-controls="Succinylcholine-DOSAGE-INDICATIONS" aria-selected="false">DOSAGE
                                INDICATIONS</a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link" id="Succinylcholine-MAXIMUM-DOSAGE-tab" data-toggle="pill"
                                href="#Succinylcholine-MAXIMUM-DOSAGE" role="tab"
                                aria-controls="Succinylcholine-MAXIMUM-DOSAGE" aria-selected="false">MAXIMUM DOSAGE</a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link" id="Succinylcholine-CONTRAINDICATIONS-PRECAUTIONS-tab"
                                data-toggle="pill" href="#Succinylcholine-CONTRAINDICATIONS-PRECAUTIONS" role="tab"
                                aria-controls="Succinylcholine-CONTRAINDICATIONS-PRECAUTIONS"
                                aria-selected="false">CONTRAINDICATIONS /
                                PRECAUTIONS</a>
                        </li>
                    </ul>
                    <div class="tab-content" id="Succinylcholine-tabContent">
                        <div class="tab-pane fade show active" id="Succinylcholine-BOXED-WARNING" role="tabpanel"
                            aria-labelledby="Succinylcholine-BOXED-WARNING-tab">
                            BOXED-WARNING
                        </div>
                        <div class="tab-pane fade" id="Succinylcholine-DOSAGE-INDICATIONS" role="tabpanel"
                            aria-labelledby="Succinylcholine-DOSAGE-INDICATIONS-tab">
                            DOSAGE-INDICATIONS
                        </div>
                        <div class="tab-pane fade" id="Succinylcholine-MAXIMUM-DOSAGE" role="tabpanel"
                            aria-labelledby="Succinylcholine-MAXIMUM-DOSAGE-tab">
                            MAXIMUM-DOSAGE
                        </div>
                        <div class="tab-pane fade" id="Succinylcholine-CONTRAINDICATIONS-PRECAUTIONS" role="tabpanel"
                            aria-labelledby="Succinylcholine-CONTRAINDICATIONS-PRECAUTIONS-tab">
                            CONTRAINDICATIONS-PRECAUTIONS
                        </div>
                    </div>
                </div>
            </div>
            <div class="tab-pane" id="Vecuronium" role="tabpanel" aria-labelledby="Vecuronium-tab">
                <div class="mainContent">
                    <ul class="nav nav-pills mb-3" id="vecuronium-tab" role="tablist">
                        <li class="nav-item">
                            <a class="nav-link active" id="vecuronium-DOSAGE-INDICATIONS-tab" data-toggle="pill"
                                href="#vecuronium-DOSAGE-INDICATIONS" role="tab"
                                aria-controls="vecuronium-DOSAGE-INDICATIONS" aria-selected="true">DOSAGE &
                                INDICATIONS</a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link" id="vecuronium-DOSING-CONSIDERATIONS-tab" data-toggle="pill"
                                href="#vecuronium-DOSING-CONSIDERATIONS" role="tab"
                                aria-controls="vecuronium-DOSING-CONSIDERATIONS" aria-selected="false">DOSING
                                CONSIDERATIONS</a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link" id="vecuronium-CONTRAINDICATIONS-PRECAUTIONS-tab" data-toggle="pill"
                                href="#vecuronium-CONTRAINDICATIONS-PRECAUTIONS" role="tab"
                                aria-controls="vecuronium-CONTRAINDICATIONS-PRECAUTIONS"
                                aria-selected="false">CONTRAINDICATIONS / PRECAUTIONS</a>
                        </li>
                    </ul>
                    <div class="tab-content" id="vecuronium-tabContent">
                        <div class="tab-pane fade show active" id="vecuronium-DOSAGE-INDICATIONS" role="tabpanel"
                            aria-labelledby="vecuronium-DOSAGE-INDICATIONS-tab">
                            DOSAGE-INDICATIONS
                        </div>
                        <div class="tab-pane fade" id="vecuronium-DOSING-CONSIDERATIONS" role="tabpanel"
                            aria-labelledby="vecuronium-DOSING-CONSIDERATIONS-tab">
                            DOSING-CONSIDERATIONS
                        </div>
                        <div class="tab-pane fade" id="vecuronium-CONTRAINDICATIONS-PRECAUTIONS" role="tabpanel"
                            aria-labelledby="vecuronium-CONTRAINDICATIONS-PRECAUTIONS-tab">
                            CONTRAINDICATIONS-PRECAUTIONS
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>





</div>